Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions

Bioequivalence

Interventions

DRUG

Diosmin/Hesperidin (90/10) 500 mg Test Drug

Investigational Medicinal Product

DRUG

Diosmin/Hesperidin (90/10) 500 mg Reference Product

Daflon (Trademark)

Trial Locations (1)

Azidus Laboratories Ltd., Chennai